Scienture Holdings, Inc.SCNX

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$0.29
Market cap
$11.8M
P/E
—
Revenue (TTM)
$821,315
Net income
-$38.0M
Dividend yield
—
1-year total return
-65.5%
Net margin
-4620.9%
Revenue growth
540.6%
Debt / equity
0.03x

What Scienture Holdings, Inc. does.

information included in this Annual Report should be read in conjunction with the consolidated financial statements and related notes

logo and some of our trademarks and tradenames are used in this Annual Report. This Annual Report may also include trademarks, tradenames

and service marks that are the property of others. Solely for convenience, trademarks, tradenames and service marks referred to in this

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$17.1M$9.9M$10.3M$1.4M$136,643$431,609
Net income-$2.5M-$5.3M-$3.5M-$17.8M$9.1M-$41.5M
Free cash flow-$2.3M-$2.6M——-$14.3M—

More on SCNX.

Figures from Scienture Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.